ANXA1 and neoplasm: Although ARID1A expression did not associate with BrC molecular subtype, HER-2+ (non-luminal) tumours depict higher ANXA1 protein levels (p < 0.001) than luminal B-like (HER-2+) tumours (Figure 3).